The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Pathogenesis of cyclosporine nephropathy: roles of angiotensin II and osteopontin.
Abstract
Low-salt-diet, cyclosporine (CsA; 15 mg/kg per day)-treated rats develop striped interstitial fibrosis, arteriolar hyalinosis, and azotemia similar to the chronic nephropathy observed in humans. To examine the role of angiotensin II in this model, rats on a low-salt diet were given CsA, CsA and the angiotensin II receptor Type I antagonist Losartan (10 mg/kg per day), CsA and hydralazine/furosemide, or vehicle. At Day 35, CsA-treated rats had tubular injury, arteriolopathy of the afferent arteriole, increased expression of the monocyte-macrophage adhesive protein osteopontin, interstitial macrophage infiltration, increased interstitial transforming growth factor-beta expression, and interstitial fibrosis. This study provides new insight in both pathogenic and therapeutic aspects of CsA nephropathy. The pathogenesis of CsA nephropathy involves the expression of osteopontin by tubular epithelial cells, the level of which closely correlates with the degree of macrophage infiltration and interstitial fibrosis in all groups (r = 0.79 and 0.74, respectively; P < 0.001). Therapeutic conclusions can be drawn from the observation that both losartan and hydralazine/furosemide reduced osteopontin expression, macrophage infiltration, transforming growth factor-beta expression, and interstitial fibrosis, but did not prevent the decrease in GFR. Treatment with losartan, but not with hydralazine and furosemide, markedly reduced arteriolopathy. It was concluded that angiotensin II contributes to the vasculopathy (hyalinosis) induced by CsA. In contrast, the interstitial fibrosis mediated by CsA can be partially prevented by both an angiotensin II Type I receptor antagonist or by hydralazine and furosemide. This suggests that the interstitial fibrosis can be dissociated from the vascular effects of CsA. The beneficial effects of lowering blood pressure or vasodilation per se may be difficult to distinguish from the specific effects of angiotensin II receptor blockade.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
CYCLOSPORIN A IN PATIENTS RECEIVING RENAL ALLOGRAFTS FROM CADAVER DONORS
Calne, R. Y., Thiru, S., Mcmaster, P., Craddock, G. N., White, D. J. G., Evans, D. B., Dunn, D. C., Pentlow, B. D., & Rolles, K. (1978) · The Lancet · doi:10.1016/s0140-6736(78)91970-0 · Cited by 1,002
Giachelli, C. M., Bae, N., Almeida, M., Denhardt, D. T., Alpers, C. E., & Schwartz, S. M. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116755 · Cited by 641
Self-citationRenal injury from angiotensin II-mediated hypertension.
Johnson, R. J., Alpers, C. E., Yoshimura, A., Lombardi, D., Pritzl, P., Floege, J., & Schwartz, S. M. (1992) · Hypertension · doi:10.1161/01.hyp.19.5.464 · Cited by 536
Self-citationInflammatory and immunomodulatory roles of TGF-β
Wahl, S. M., McCartney-Francis, N., & Mergenhagen, S. E. (1989) · Immunology Today · doi:10.1016/0167-5699(89)90136-9 · Cited by 449
Effect of cyclosporine administration on renal hemodynamics in conscious rats
Murray, B. M., Paller, M. S., & Ferris, T. F. (1985) · Kidney International · doi:10.1038/ki.1985.196 · Cited by 419
Sustained expression of TGF-β1 underlies development of progressive kidney fibrosis
Yamamoto, T., Noble, N. A., Miller, D. E., & Border, W. A. (1994) · Kidney International · doi:10.1038/ki.1994.122 · Cited by 405
Floege, J., Burns, M. W., Alpers, C. E., Yoshimura, A., Pritzl, P., Gordon, K., Seifert, R. A., Bowen-Pope, D. F., Couser, W. G., & Johnson, R. J. (1992) · Kidney International · doi:10.1038/ki.1992.42 · Cited by 404
Self-citationShiraga, H., Min, W., VanDusen, W. J., Clayman, M. D., Miner, D., Terrell, C. H., Sherbotie, J. R., Foreman, J. W., Przysiecki, C., & Neilson, E. G. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.1.426 · Cited by 390
Wolf, G., Mueller, E., Stahl, R. A., & Ziyadeh, F. N. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116710 · Cited by 379
Patarca, R., Freeman, G. J., Singh, R. P., Wei, F. Y., Durfee, T., Blattner, F., Regnier, D. C., Kozak, C. A., Mock, B. A., & Morse, H. C. (1989) · The Journal of experimental medicine · doi:10.1084/jem.170.1.145 · Cited by 322
Increased synthesis of extracellular matrix in mesangial proliferative nephritis
Floege, J., Johnson, R. J., Gordon, K., Iida, H., Pritzl, P., Yoshimura, A., Campbell, C., Alpers, C. E., & Couser, W. G. (1991) · Kidney International · doi:10.1038/ki.1991.235 · Cited by 264
Self-citationExpression of transforming growth factor-β1 during diabetic renal hypertrophy
Shankland, S. J., Scholey, J. W., Ly, H., & Thai, K. (1994) · Kidney International · doi:10.1038/ki.1994.291 · Cited by 233
Self-citationOsteopontin expression in angiotensin II-induced tubulointerstitial nephritis
Giachelli, C. M., Pichler, R., Lombardi, D., Denhardt, D. T., Alpers, C. E., Schwartz, S. M., & Johnson, R. J. (1994) · Kidney International · doi:10.1038/ki.1994.67 · Cited by 226
Self-citationSingh, R. P., Patarca, R., Schwartz, J., Singh, P., & Cantor, H. (1990) · The Journal of experimental medicine · doi:10.1084/jem.171.6.1931 · Cited by 226
Glomerular hemodynamics and hormonal participation on cyclosporine nephrotoxicity
Barros, E. J. G., Boim, M. A., Ajzen, H., Ramos, O. L., & Schor, N. (1987) · Kidney International · doi:10.1038/ki.1987.166 · Cited by 208
Johnson, R. J., Garcia, R. L., Pritzl, P., & Alpers, C. E. (1990) · PubMed Central · Cited by 191
Self-citationTubulointerstitial disease in glomerulonephritis. Potential role of osteopontin (uropontin).
Pichler, R. H., Giachelli, C. M., Lombardi, D. M., Pippin, J. W., GORDON, K. L., Alpers, C. E., Schwartz, S. M., & Johnson, R. J. (1994) · PubMed · Cited by 174
Self-citationIsolation, Characterization and Immunolocalization of a 53-kDal Dentin Sialoprotein (DSP)
Butler, W. T., Bhown, M., Brunn, J. C., D’Souza, R. N., Farach‐Carson, M. C., Happonen, R.-P., Schrohenloher, R. E., Seyer, J. M., Somerman, M. J., Foster, R. A., et al. (1992) · Matrix · doi:10.1016/s0934-8832(11)80030-2 · Cited by 140
Pathogenesis of interstitial fibrosis in chronic purine aminonucleoside nephrosis
Jones, C. L., Buch, S. J., Post, M., McCulloch, L., Liu, E., & Eddy, A. A. (1991) · Kidney International · doi:10.1038/ki.1991.310 · Cited by 135
The mouse osteopontin gene. Expression in monocytic lineages and complete nucleotide sequence.
Miyazaki, Y., Setoguchi, M., Yoshida, S., Higuchi, Y., Akizuki, S., & Yamamoto, S. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)77320-1 · Cited by 123
MODIFICATION OF EXPERIMENTAL NEPHROTOXICITY WITH FISH OIL AS THE VEHICLE FOR CYCLOSPORINE
Elzinga, L. W., Kelley, V. E., Houghton, D. C., & Bennett, W. M. (1987) · Transplantation · doi:10.1097/00007890-198702000-00021 · Cited by 99
Self-citationCaptopril-induced fall in glomerular filtration rate in cyclosporine-treated hypertensive patients.
Curtis, J. J., Laskow, D. A., Jones, P., Julian, B. A., Gaston, R. S., & Luke, R. G. (1993) · Journal of the American Society of Nephrology · doi:10.1681/asn.v391570 · Cited by 60
Cited by
Chronic Renal Failure after Transplantation of a Nonrenal Organ
Ojo, A. O., Held, P. J., Port, F. K., Wolfe, R. A., Leichtman, A. B., Young, E. W., Arndorfer, J., Christensen, L., & Merion, R. M. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021744 · Cited by 2,220
Costanzo, M. R., Costanzo, M. R., Dipchand, A., Starling, R., Anderson, A., Chan, M., Desai, S., Fedson, S., Fisher, P., Gonzales-Stawinski, G., et al. (2010) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2010.05.034 · Cited by 1,653
Calcineurin Inhibitor Nephrotoxicity
Naesens, M., Kuypers, D. R. J., & Sarwal, M. (2009) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.04800908 · Cited by 1,489
Inflammation and angiotensin II
Suzuki, Y., Ruiz-Ortega, M., Lorenzo, O., Ruperez, M., Esteban, V., & Egido, J. (2003) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(02)00271-6 · Cited by 694
Molecular insights into renal interstitial fibrosis.
Eddy, A. A. (1996) · Journal of the American Society of Nephrology · doi:10.1681/asn.v7122495 · Cited by 637
Metadata
- Authors
- Pichler, R. H., Franceschini, N., Young, B. A., Hugo, C., Andoh, T. F., Burdmann, E. A., Shankland, S. J., Alpers, C. E., Bennett, W. M., & Couser, W. G.
- Venue
- Journal of the American Society of Nephrology
- Published
- 1995-10
- Volume
- 6
- Issue
- 4
- Pages
- 1186-1196
- ISSN
- 1046-6673 (ISSN-L)
- OpenAlex
- W2098945680
- Cited by
- 256
- References
- 22
- FWCI
- 10.30
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.